329 related articles for article (PubMed ID: 32393082)
1. Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis.
Fereig SA; El-Zaafarany GM; Arafa MG; Abdel-Mottaleb MMA
Drug Deliv; 2020 Dec; 27(1):662-680. PubMed ID: 32393082
[TBL] [Abstract][Full Text] [Related]
2. Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier.
Ramanunny AK; Wadhwa S; Thakur D; Singh SK; Kumar R
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):418-433. PubMed ID: 32496998
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis.
Gomes GS; Frank LA; Contri RV; Longhi MS; Pohlmann AR; Guterres SS
Int J Pharm; 2023 Jan; 631():122535. PubMed ID: 36566826
[TBL] [Abstract][Full Text] [Related]
4. Delivery and Anti-Psoriatic Effect of Silibinin-Loaded Polymeric Micelles: An Experimental Study in the Psoriatic Skin Model.
Chavoshy F; Zadeh BSM; Tamaddon AM; Anbardar MH
Curr Drug Deliv; 2020; 17(9):787-798. PubMed ID: 32703129
[TBL] [Abstract][Full Text] [Related]
5. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
Gungor S; Rezigue M
Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
[TBL] [Abstract][Full Text] [Related]
6. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
Doppalapudi S; Jain A; Chopra DK; Khan W
Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
[TBL] [Abstract][Full Text] [Related]
7. Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis.
Saleem S; Iqubal MK; Garg S; Ali J; Baboota S
Expert Opin Drug Deliv; 2020 Jun; 17(6):817-838. PubMed ID: 32315216
[TBL] [Abstract][Full Text] [Related]
8. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
Pradhan M; Singh D; Singh MR
Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290
[TBL] [Abstract][Full Text] [Related]
9. Vesicles: Potential nano carriers for the delivery of skin cosmetics.
Lohani A; Verma A
J Cosmet Laser Ther; 2017 Dec; 19(8):485-493. PubMed ID: 28753057
[TBL] [Abstract][Full Text] [Related]
10. Exploration of and insights into advanced topical nanocarrier systems for the treatment of psoriasis.
Zhang M; Hong S; Sun X; Zhou Y; Luo Y; Liu L; Wang J; Wang C; Lin N; Li X
Front Med (Lausanne); 2022; 9():1017126. PubMed ID: 36590975
[TBL] [Abstract][Full Text] [Related]
11. A Promising Approach of Dermal Targeting of Antipsoriatic Drugs
Tripathi D; Srivastava M; Rathour K; Rai AK; Wal P; Sahoo J; Tiwari RK; Pandey P
Drug Metab Bioanal Lett; 2023; 16(2):89-104. PubMed ID: 37534794
[TBL] [Abstract][Full Text] [Related]
12. From Traditional Medicine to Advanced Therapeutics: The Renaissance of Phyto-nano Interventions in Psoriasis.
Semele R; Grewal S; Jeengar MK; Singh TG; Swami R
Recent Adv Inflamm Allergy Drug Discov; 2024; 18(1):27-42. PubMed ID: 37921124
[TBL] [Abstract][Full Text] [Related]
13. Exploring the potential of nanocarriers in antipsoriatic therapeutics.
Shaif M; Kushwaha P; Usmani S; Pandey S
J Dermatolog Treat; 2022 Nov; 33(7):2919-2930. PubMed ID: 35729857
[TBL] [Abstract][Full Text] [Related]
14. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
Kaur N; Sharma K; Bedi N
Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
[TBL] [Abstract][Full Text] [Related]
15. Emerging Technologies to Target Drug Delivery to the Skin - the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone.
Schneider-Rauber G; Argenta DF; Caon T
Pharm Res; 2020 Nov; 37(12):240. PubMed ID: 33169237
[TBL] [Abstract][Full Text] [Related]
16. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Sathe P; Saka R; Kommineni N; Raza K; Khan W
Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
[TBL] [Abstract][Full Text] [Related]
17. An Innovative Approach in Nanotechnology-based Delivery System for the Effective Management of Psoriasis.
Parveen S; Ahmed M; Baboota S; Ali J
Curr Pharm Des; 2022; 28(13):1082-1102. PubMed ID: 35105284
[TBL] [Abstract][Full Text] [Related]
18. Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles.
Boisgard AS; Lamrayah M; Dzikowski M; Salmon D; Kirilov P; Primard C; Pirot F; Fromy B; Verrier B
Eur J Pharm Biopharm; 2017 Jul; 116():51-60. PubMed ID: 27702687
[TBL] [Abstract][Full Text] [Related]
19. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
20. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q
J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
